Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.
Patent CN116063223A reveals a metal-free TfOH catalyzed route for 10-perfluoroalkyl-5,10-dihydroindeno[1,2-b]indoles, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Patent CN114014802A details a mild Pd-catalyzed dehydrogenative coupling for enamides, offering cost reduction in pharmaceutical intermediate manufacturing via scalable routes.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Novel synthesis route avoids explosive diazo compounds, offering high purity and scalable production for pharmaceutical intermediates globally.
Patent CN113307778A details a novel Mo/Cu co-catalyzed synthesis of 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN112694430B details a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high yields and simplified processing for API manufacturing.
Patent CN112538045A reveals a mild copper-catalyzed route to quinolines, offering cost reduction in API manufacturing and scalable green chemistry solutions.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN114308121A discloses novel phosphine oxide catalysts enabling catalytic Mitsunobu reactions. Achieve high stereoselectivity, reduced waste, and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis for high-purity antitumor intermediates, offering significant cost reduction and supply reliability.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel glucose-based route for 3-CF3-1,2,4-triazoles. Mild conditions, high efficiency, scalable process for pharmaceutical intermediates.
Patent CN115353511A details a mild, multi-component synthesis route for carbonyl-bridged biheterocycles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed bis-carbonylation route for pyrrol-2-one scaffolds offering high yields and simplified purification for pharmaceutical applications.
Efficient synthesis of N-acyl indoles using Pd-catalyzed carbonylation. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis route for trifluoromethyl triazoles, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN104945339B reveals efficient one-pot synthesis. Delivers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Novel rhodium-catalyzed route offers high purity trifluoromethyl enaminones. Reduces manufacturing costs and ensures supply chain reliability for global pharmaceutical partners.